Esocon 20 mg (Capsule (Enteric Coated))
Unit Price: ৳ 7.00 (10 x 10: ৳ 700.00)
Strip Price: ৳ 70.00
Medicine Details
Category | Details |
---|---|
Generic | Esomeprazole |
Company | Biopharma limited |
Also available as |
Indications
- Relief from chronic heartburn symptoms
- Healing of erosive esophagitis
- Maintenance of healing of erosive esophagitis
- Eradication of Helicobacter pylori infection in patients with duodenal ulcer disease
- Treatment for Zollinger-Ellison Syndrome
- Treatment for acid-related dyspepsia
- Treatment for duodenal and gastric ulcer
Pharmacology
- Mechanism of action: Proton pump inhibitor that suppresses gastric acid secretion
- Absorption: Peak plasma levels occur at approximately 1.5 hours after oral administration
- Distribution: 97% bound to plasma proteins
- Metabolism: Extensively metabolized in the liver by the cytochrome P450 (CYP) enzyme system
- Excretion: Plasma elimination half-life is approximately 1–1.5 hours
Dosage
- 20 mg or 40 mg Once Daily for 4-8 Weeks for healing of erosive esophagitis
- 20 mg Once Daily for maintenance of healing of erosive esophagitis
- 20 mg Once Daily for symptomatic GERD for 4 Weeks
- Triple Therapy (Esomeprazole 40 mg Once Daily, Amoxicillin 1000 mg Twice Daily, Clarithromycin 500 mg Twice Daily) for 10 days for Helicobacter pylori eradication
- Dose of 20-80 mg once daily for Zollinger-Ellison Syndrome
- 20-40 mg once daily for 2-4 weeks for acid-related dyspepsia
- 20 mg once daily for 2-4 weeks for duodenal ulcer, 20-40 mg once daily for 4-8 weeks for gastric ulcer
- Dosage for IV Injection or IV infusion varies for different conditions and patient age groups
Administration
- Tablet or capsule should be swallowed whole and taken one hour before a meal
- Oral Suspension should be taken with water and consumed within 30 minutes
- IV Injection must be administrated intravenously over a period of at least 3 minutes
Interactions
- Metabolized in the liver by CYP2C19 and CYP3A4
- Not likely to inhibit certain CYP enzymes
- May interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability
Contraindications
- Known hypersensitivity to any of the formulation
Side Effects
- Headache
- Diarrhoea
- Nausea
- Flatulence
- Abdominal pain
- Constipation
- Dry mouth
Pregnancy & Lactation
- No adequate and well-controlled studies in pregnant women
- Animal studies have revealed no teratogenic effects
- Breast-feeding should be discontinued if the use of esomeprazole is considered essential
Precautions & Warnings
- Symptomatic response does not preclude the presence of gastric malignancy
- Patients should take capsules at least one hour before meals
- Antacids may be used while taking Esocon
Use in Special Populations
- Safety and effectiveness in pediatric patients have not been established
- No overall differences in safety and efficacy between the elderly and younger individuals
- No dosage adjustment is recommended for patients with mild to moderate hepatic insufficiency
- Pharmacokinetics not expected to be altered in patients with renal impairment
Overdose Effects
- Major signs of acute toxicity are reduced motor activity, changes in respiratory frequency, tremor, ataxia, and intermittent clonic convulsions
- No specific antidote known
- Treatment should be symptomatic and supportive
Storage Conditions
- Store at a temperature not exceeding 30°C in a dry place, protect from light and moisture
Chemical Structure
- Molecular Formula: C17H19N3O3S
Common Questions
- Esocon 20 mg Capsule is a proton pump inhibitor (PPI) used to reduce the amount of acid produced in the stomach
- Used to treat gastroesophageal reflux disease (GERD), ulcers, and other conditions involving excess stomach acid
- Common side effects include headaches, diarrhea, nausea, and constipation
- Pregnant or breastfeeding women should consult a doctor
Related Brands
- Esocare 40 mg (Capsule (Enteric Coated)) - novelta-bestway-pharma-ltd
- Esocare 20 mg (Capsule (Enteric Coated)) - novelta-bestway-pharma-ltd
- ESO 20 mg (Tablet (Enteric Coated)) - asiatic-laboratories-ltd
- Esmotac 40 mg (Tablet (Enteric Coated)) - gaco-pharmaceuticals-ltd
- Esmotac 20 mg (Tablet (Enteric Coated)) - gaco-pharmaceuticals-ltd